News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Courtney Moc, PharmD, MS

Advertisement

Articles by Courtney Moc, PharmD, MS

Current and Potential Treatment Options for Stenotrophomonas maltophilia Infections

ByCourtney Moc, PharmD, MS,Samuel L. Aitken, PharmD, MPH
August 18th 2020

We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.

Advertisement

Latest Updated Articles

  • Current and Potential Treatment Options for Stenotrophomonas maltophilia Infections
    Current and Potential Treatment Options for Stenotrophomonas maltophilia Infections

    Published: August 18th 2020 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Nearly 1 in 5 Urinary Tract Infections in Southern California Linked to Contaminated Meat

2

Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint

3

Risk Stratification, Testing, and Treatment in Recurrent Clostridioides difficile

4

High Continued Adherence of Lenacapavir in Individuals Who Use Substances and Alcohol

5

Dynavax Presents Data for Shingles Vaccine, Launches Head-to-Head Study Against Shingrix

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us